Active Ingredient (In Each Patch)
Retatrutide 20 mg ……………………………. Weight management / blood sugar control
Esokalli Slimming Microcrystalline Patch
FDA Label NDC 84778-082
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Guangzhou Yixin Cross-border E-commerce Co., Ltd. for the product Esokalli Slimming Microcrystalline Patch (NDC 84778-082). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each patch), purpose, uses, warnings, dosage and administration, do not use if you, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Weight loss aid
Improves blood sugar control (when used with diet and exercise)
Uses
To support weight management
To improve glycemic control in adults with type 2 diabetes mellitus
Provides long-acting sustained-release delivery via soluble microneedle patch
Warnings
For external use only
Dosage And Administration
• Apply one transdermal patch containing 20 mg Retatrutide to the wrist or the back of the hand.
• Leave the patch in place for 30 to 60 minutes, then remove.
• Administer once every 3 to 7 days.
• Do not reuse a patch.
• Use only as directed.
Do Not Use If You
• have type 1 diabetes
• need treatment for diabetic ketoacidosis
• are pregnant or breastfeeding
• are under 18 years of age
• have severe heart disease
• have skin disease or broken skin at the application site
• have a history of hypoglycemia
• are allergic to any ingredient in this product
When Using This Product
• monitor blood glucose regularly
• possible side effects include:
– hypoglycemia
– nausea, vomiting, or diarrhea
– acute pancreatitis
– complications of diabetic retinopathy
– increased heart rate
– hypersensitivity or allergic reactions
Stop Use And Ask A Doctor If
• you develop severe abdominal pain (possible acute pancreatitis)
• symptoms of hypersensitivity occur (rash, swelling, difficulty breathing)
• persistent gastrointestinal problems occur
Keep Out Of Reach Of Children.
In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
Inactive Ingredients
Microcrystalline matrix, soluble microneedle polymer blend, stabilizers, adhesive layer.
Principal Display Panel
1 (20250828 01)
2 (20250828 02)
3 (20250828 03)
4 (20250828 04)
* Please review the disclaimer below.
